About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Depression Clinical Trials in Chicago | 177 Studies

Clinical Trials DepressionChicago

Depression Clinical Trials in Chicago

Find 177 clinical trials for depression near Chicago, Illinois. Connect with research centers in your area.

All Depression trials nationwide All trials in Chicago

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 121-140 of 177 trials

RecruitingA Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)The goal of this clinical trial is to learn if a drug called TNX-102 SL works to treat moderate to severe major depressive disorder in adults.NCT07621237·Phoenix, Arizona and 26 others

Depression Trials in Other Cities

New York Los Angeles Houston Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedMicrobiomes of Pelvic PainThis research study seeks to provide more insight as to how the microbiome affects or is affected by conditions causing chronic pelvic pain such as Interstitial Cystitis (IC)…NCT01738464·Chicago, Illinois

CompletedPilot Study in Multi-Coil Repetitive Transcranial Magnetic Stimulation (rTMS) for Treatment Resistant DepressionThe purpose of this study is to assess the efficacy of a Deep Shaped-Field repetitive transcranial magnetic stimulation (DSF-rTMS) system in the treatment of depression.NCT01431001·Atlanta, Georgia and 3 others

CompletedChicago Urban Resiliency Building (CURB)The purpose of the study is to determine whether a culturally tailored, low-cost, primary care/internet based depression prevention intervention (CURB) is superior to wait-list…NCT01571011·Chicago, Illinois

CompletedA Study to Evaluate the Efficacy and Safety of JNJ-42847922 as Adjunctive Therapy to Antidepressants in Adult Participants With Major Depressive Disorder Who Have Responded Inadequately to Antidepressant TherapyThe purpose of this study is to assess the dose-response relationship of 2 doses of JNJ-42847922 before interim analysis, and potentially 3 doses based on interim analysis…NCT03227224·Anaheim, California and 100 others

CompletedEfficacy and Safety Study of Vortioxetine (Lu AA21004) in Adults With Major Depressive DisorderThe purpose of this study is to evaluate the efficacy of vortioxetine, once daily (QD), compared with placebo in adults with major depressive disorder.NCT01163266·Anaheim, California and 38 others

CompletedSafety and Efficacy of Levomilnacipran ER (F2695 SR) in Major Depressive DisorderThe purpose of this study is to evaluate the efficacy, safety, and tolerability of Levomilnacipran ER versus placebo in the treatment of outpatients with major depressive disorderNCT01034462·Dothan, Alabama and 22 others

CompletedMelatonin Agonist Effects of Tasimelteon Versus Placebo in Patients With Major Depressive DisorderThe purpose of this study is to evaluate the safety and efficacy of an 8-week double-masked treatment of tasimelteon or placebo in male and female subjects with Major Depressive…NCT01428661·Garden Grove, California and 39 others

Active not recruitingA Phase 3 Trial of DT120 for Major Depressive Disorder (Emerge)A Phase 3 Double-blind, Placebo-controlled Study (Part A) with an Open-label Extension (Part B) Evaluating DT120 Compared to Placebo in Major Depressive Disorder - EmergeNCT06941844·Little Rock, Arkansas and 21 others

CompletedAn Efficacy and Safety Study of Sirukumab in Participants With Major Depressive DisorderThe purpose of this study is to evaluate the efficacy of sirukumab as adjunctive treatment to antidepressant therapy (monoaminergic antidepressant) where sirukumab (administered…NCT02473289·Birmingham, Alabama and 45 others

RecruitingMulticenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE.Phase II study for patients with Bipolar 1 Disorder experiencing major depressive episode.NCT07494305·Bentonville, Arkansas and 25 others

CompletedStudy to Evaluate the Efficacy and Safety of 3 Fixed Doses of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Pediatric Participants Assessed to be at Imminent Risk for SuicideThe purpose of this study is to assess the efficacy of a single (first) dose of 3 fixed doses of intranasal esketamine {28 milligram (mg), 56 mg, and 84 mg} compared with…NCT03185819·Hartford, Connecticut and 50 others

CompletedLong-Term Safety Of DVS-233 SR In Patients With Major Depressive DisorderThe study evaluated the long-term safety of Desvenlafaxine Succinate (DVS) Slow Release (SR) during open-label treatment in adult outpatients who had a primary diagnosis of major…NCT01309542·Birmingham, Alabama and 116 others

CompletedEfficacy and Safety Study of BHV-7000 Monotherapy in Major DepressionThe purpose of this study is to determine the efficacy and safety of BHV-7000 in participants with Major Depressive Disorder (MDD)NCT06419608·Phoenix, Arizona and 61 others

CompletedMechanistic Evaluation of Response in TRD (MERIT)To evaluate the relapse prevention of AXS-05 relative to placebo in subjects with treatment resistant depression (TRD).NCT04608396·Little Rock, Arkansas and 19 others

CompletedEffectiveness of a Technology Assisted Behavioral Intervention in Assisting People With Major Depressive DisorderThis study will develop and evaluate the effectiveness of a technology-assisted behavioral intervention, consisting of Internet-based cognitive behavioral therapy combined with…NCT00719979·Chicago, Illinois

TerminatedA Study to Assess the Efficacy and Safety of REL-1017 as Adjunctive Treatment for Major Depressive Disorder (MDD)This is an outpatient, 2-arm, Phase 3, multicenter, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of REL-1017 once daily (QD) as an…NCT04855747·Homewood, Alabama and 69 others

RecruitingTreatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)The goal of this clinical trial is to evaluate the effectiveness and safety of bilateral stimulation of the subcallosal cingulate white matter (SCCwm) using Deep Brain Stimulation…NCT06423430·Birmingham, Alabama and 24 others

RecruitingTransition Care for FEPThis study is testing a new approach to help people with first episode psychosis transition successfully from the hospital to outpatient mental health care.NCT07713849·Chicago, Illinois and 1 other

CompletedSafety and Efficacy of Levomilnacipran ER (Levomilnacipran SR) in Major Depressive DisorderThe purpose of this study is to evaluate the efficacy, safety, and tolerability of Levomilnacipran ER compared to placebo in patients with Major Depressive Disorder (MDD).NCT01377194·Birmingham, Alabama and 50 others

PreviousPage 7 of 9Next

Other Conditions in Chicago

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia